Ikena Oncology Inc
NASDAQ:IKNA 4:00:00 PM EDT
Ikena Oncology Inc Stock, NASDAQ:IKNA
645 Summer Street, Suite 101, Boston, Massachusetts 02210
United States of America
Phone: +1.857.273.8343
Number of Employees: 10
Description
Ikena Oncology, Inc. is a clinical stage biotechnology company, which engages in the development of patient directed and biomarker driven therapies for cancer patients. Its product pipeline includes IK-930, RAS Signaling, IK-175, IK-412, and IK-007. The company was founded by Mark Manfredi and George Georgiou in February 2016 and is headquartered in Boston, MA.